Form 4: Apellis Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Nur Nicholson, Chief Technical Officer of Apellis Pharmaceuticals, sold 2,632 shares of common stock on January 13, 2025, to cover tax withholding related to released Restricted Stock Units.

Summary

• On January 13, 2025, Nur Nicholson, the Chief Technical Officer of Apellis Pharmaceuticals, sold 2,632 shares of the company's common stock.
• The sale was executed at a price of $28.7021 per share.
• This transaction was conducted to cover tax withholding obligations associated with Restricted Stock Units that were released on January 10, 2025.
• Following the transaction, Nicholson directly owns 54,156 shares of Apellis Pharmaceuticals.
• This total includes 501 shares acquired through the Employee Stock Purchase Plan (ESPP) on April 30, 2024.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with stock-based compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.

Key Dates